Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia

• Prif Awduron: Wu Yang (Awdur), Xiao-e Wang (Awdur), Jia-le Gu (Awdur), Li-juan Ma (Awdur), Bai-ge Su (Awdur), Hui-jie Xiao (Awdur), Yong Yao (Awdur), Hong-wen Zhang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Editorial Department of Journal of Clinical Nephrology, 2024-02-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

ObjectiveRituximab (RTX) has been widely used for primary nephrotic syndrome (PNS) in children of frequent relapse or hormonal dependence. The authors applied RTX for childhood PNS in Ningxia for the first time and examined its efficacy.MethodsFrom January 1, 2020 to December 31, 2022, 7 PNS childre...